Title |
The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
|
---|---|
Published in |
BMC Infectious Diseases, October 2020
|
DOI | 10.1186/s12879-020-05507-4 |
Pubmed ID | |
Authors |
Naser Gharebaghi, Rahim Nejadrahim, Seyed Jalil Mousavi, Seyyed-Reza Sadat-Ebrahimi, Reza Hajizadeh |
X Demographics
The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 13% |
Malaysia | 1 | 6% |
Japan | 1 | 6% |
France | 1 | 6% |
Unknown | 11 | 69% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 12 | 75% |
Practitioners (doctors, other healthcare professionals) | 2 | 13% |
Science communicators (journalists, bloggers, editors) | 1 | 6% |
Scientists | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 160 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 160 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 16 | 10% |
Other | 14 | 9% |
Student > Master | 14 | 9% |
Researcher | 13 | 8% |
Student > Doctoral Student | 9 | 6% |
Other | 27 | 17% |
Unknown | 67 | 42% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 40 | 25% |
Nursing and Health Professions | 13 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 12 | 8% |
Biochemistry, Genetics and Molecular Biology | 5 | 3% |
Immunology and Microbiology | 3 | 2% |
Other | 13 | 8% |
Unknown | 74 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 87. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2021.
All research outputs
#493,787
of 25,494,370 outputs
Outputs from BMC Infectious Diseases
#123
of 8,637 outputs
Outputs of similar age
#14,233
of 440,087 outputs
Outputs of similar age from BMC Infectious Diseases
#3
of 169 outputs
Altmetric has tracked 25,494,370 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,637 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,087 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 169 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.